236 related articles for article (PubMed ID: 9595545)
1. Plasma (total and ionized), erythrocyte and platelet magnesium levels in renal transplant recipients during cyclosporine and/or azathioprine treatment.
Allegra A; Corica F; Ientile R; Corsonello A; Sparacino V; Accettola F; Caputo F; Macaione S; Buemi M
Magnes Res; 1998 Mar; 11(1):11-8. PubMed ID: 9595545
[TBL] [Abstract][Full Text] [Related]
2. Long-term calcineurin inhibition and magnesium balance after renal transplantation.
Mazzola BL; Vannini SD; Truttmann AC; von Vigier RO; Wermuth B; Ferrari P; Bianchetti MG
Transpl Int; 2003 Feb; 16(2):76-81. PubMed ID: 12595968
[TBL] [Abstract][Full Text] [Related]
3. Permanently reduced plasma ionized magnesium among renal transplant recipients on cyclosporine.
Vannini SD; Mazzola BL; Rodoni L; Truttmann AC; Wermuth B; Bianchetti MG; Ferrari P
Transpl Int; 1999; 12(4):244-9. PubMed ID: 10460868
[TBL] [Abstract][Full Text] [Related]
4. Ionized and total magnesium levels in cyclosporin-treated renal transplant recipients: relationship with cholesterol and cyclosporin levels.
Markell MS; Altura BT; Barbour RL; Altura BM
Clin Sci (Lond); 1993 Sep; 85(3):315-8. PubMed ID: 8403804
[TBL] [Abstract][Full Text] [Related]
5. Impact of cyclosporin immunosuppression on serum magnesium and its fractional excretion in renal transplant recipients.
Nawaz SH; Zafar MN; Naqvi SA; Rizvi SA
J Pak Med Assoc; 2005 Mar; 55(3):98-100. PubMed ID: 15852743
[TBL] [Abstract][Full Text] [Related]
6. Correlation between serum magnesium and blood cyclosporine A concentrations in renal transplant recipients.
Thakur V; Kumar R; Dhawan IK
Ann Clin Biochem; 2002 Jan; 39(Pt 1):70-2. PubMed ID: 11853195
[TBL] [Abstract][Full Text] [Related]
7. Cyclosporine withdrawal improves long-term graft survival in renal transplantation.
Gallagher M; Jardine M; Perkovic V; Cass A; McDonald S; Petrie J; Eris J
Transplantation; 2009 Jun; 87(12):1877-83. PubMed ID: 19543068
[TBL] [Abstract][Full Text] [Related]
8. Skeletal muscle magnesium content during cyclosporin and azathioprine treatment in renal transplant recipients.
Frost L; Danielsen H; Dørup I; Kjaer T; Pedersen EB
Nephrol Dial Transplant; 1993; 8(1):79-83. PubMed ID: 8381943
[TBL] [Abstract][Full Text] [Related]
9. Influence of immunosuppressive therapy on lipoprotein(a) and other lipoproteins following renal transplantation.
Brown JH; Murphy BG; Douglas AF; Short CD; Bhatnagar D; Mackness MI; Hunt LP; Doherty CC; Durrington PN
Nephron; 1997; 75(3):277-82. PubMed ID: 9069448
[TBL] [Abstract][Full Text] [Related]
10. Detailed study of changes in renal function after conversion from cyclosporine to azathioprine.
Hilbrands LB; Hoitsma AG; Wetzels JF; Koene RA
Clin Nephrol; 1996 Apr; 45(4):230-5. PubMed ID: 8861797
[TBL] [Abstract][Full Text] [Related]
11. Comparison of adrenal functions in kidney transplant recipients with different long-term immunosuppressive treatments--prednisolone and azathioprine versus prednisolone and cyclosporine.
Oka K; Shimodaira H; Hirano T; Sakurai E; Tamaki T; Kozaki M
Transplantation; 1993 Sep; 56(3):603-9. PubMed ID: 8212155
[TBL] [Abstract][Full Text] [Related]
12. Conversion of cyclosporine to azathroprine in renal transplant recipients.
Bassiri A; Amiranssari B; Gol S
Transplant Proc; 1995 Oct; 27(5):2691. PubMed ID: 7482877
[No Abstract] [Full Text] [Related]
13. The impact of long-term cyclosporin-A therapy on hematological and biochemical profile in renal transplant patients.
Islam SI; Ezeamuzie CI; Shaheen FA; Sheikh IA; Masuda QN; Khaleel MH
Int J Clin Pharmacol Ther; 1995 Jun; 33(6):315-21. PubMed ID: 7582381
[TBL] [Abstract][Full Text] [Related]
14. Endothelial dysfunction in renal transplant recipients maintained on cyclosporine.
Morris ST; McMurray JJ; Rodger RS; Farmer R; Jardine AG
Kidney Int; 2000 Mar; 57(3):1100-6. PubMed ID: 10720962
[TBL] [Abstract][Full Text] [Related]
15. Calcium-phosphorus-magnesium homeostasis in pregnant women after renal transplantation.
Czajkowski K; Wójcicka-Bentyn J; Grymowicz M; Smolarczyk R; Malinowska-Polubiec A; Romejko E
Int J Gynaecol Obstet; 2003 Feb; 80(2):111-6. PubMed ID: 12566182
[TBL] [Abstract][Full Text] [Related]
16. Neoquadruple induction with antithymocyte globulin/azathioprine/cyclosporine/prednisolone in simultaneous pancreas and kidney transplant recipients: 8.5-year results.
Schulz T; Kapischke M; Busing M
Transplant Proc; 2005 May; 37(4):1815-7. PubMed ID: 15919475
[TBL] [Abstract][Full Text] [Related]
17. Steroid and azathioprine versus steroid, cyclosporine, and azathioprine therapies in primary haplo-identical living donor kidney transplantation: twenty-year experience.
Gheith OA; Bakr MA; Fouda MA; Shokeir AA; Bayoumy A; Sobh M; Ghoneim M
Iran J Kidney Dis; 2008 Jan; 2(1):34-9. PubMed ID: 19367007
[TBL] [Abstract][Full Text] [Related]
18. Platelet aggregation and peripheral serotonergic system in kidney transplant recipients treated with cyclosporine.
Malyszko J; Pawlak D; Pawlak K; Malyszko JS; Buczko W; Azzudin A; Mysliwiec M
Transplant Proc; 1996 Jun; 28(3):1954-7. PubMed ID: 8658959
[No Abstract] [Full Text] [Related]
19. Hyperhomocyst(e)inemia in chronic stable renal transplant patients.
Machado DJ; Paula FJ; Sabbaga E; Ianhez LE
Rev Hosp Clin Fac Med Sao Paulo; 2000; 55(5):161-8. PubMed ID: 11175576
[TBL] [Abstract][Full Text] [Related]
20. Hyperhomocysteinemia in cyclosporine-treated renal transplant recipients.
Arnadottir M; Hultberg B; Vladov V; Nilsson-Ehle P; Thysell H
Transplantation; 1996 Feb; 61(3):509-12. PubMed ID: 8610370
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
